Seeking Alpha
2025-07-26 19:15:55

Key deals this week: Sanofi, SentinelOne, Marex Group, Synovus Financial, Union Pacific and more

Vertiv ( NYSE: VRT ) has agreed to acquire the Great Lakes Data Racks & Cabinets family of companies for $200 million. Vicebio, a biopharmaceutical company developing novel vaccines against life-threatening respiratory viral infections, has entered an exclusive, definitive agreement to be acquired by Sanofi ( NASDAQ: SNY ). SentinelOne ( NYSE: S ) jumped 18%, though pared a gain to 8.6% amid speculation that Palo Alto Networks ( NASDAQ: PANW ) may be in talks to acquire the cybersecurity firm. Marex Group ( NASDAQ: MRX ) has agreed to acquire UK equity market maker Winterflood Securities (Winterflood) from Close Brothers for about £103.9 million in cash, which represents a premium of £15 million. Pinnacle Financial ( NASDAQ: PNFP ) and Synovus Financial ( NYSE: SNV ) announced an agreement to combine in all-stock transaction valued at $8.6 billion. Shares of Synovus fell 9.2% in after hours trading, while Pinnacle dropped 5%. Union Pacific ( NYSE: UNP ) and Norfolk Southern ( NYSE: NSC ) confirmed that the railroad operators are in advanced talks regarding a potential business combination. Union Pacific fell 2.8%, while Norfolk Southern rose 1.1%. Waystar ( NASDAQ: WAY ) said it will acquire health AI software company, Iodine Software, for a total enterprise value of $1.25B. Cenovus Energy ( NYSE: CVE ) is meanwhile said to be preparing a bid for MEG Energy ( OTCPK:MEGEF ), setting up a potential challenge to Strathcona Resources' ( OTCPK:STHRF ) hostile takeover offer. More on M&A tickers, etc. SentinelOne Is Ripe For A Takeover, But Still Not A Buy Mergers & Aquisitions Slide Deck Sanofi gets EU nod for Sarclisa combination in multiple myeloma Union Pacific upped to buy at Jefferies on Norfolk Southern deal talks

Get Crypto Newsletter
Read the Disclaimer : All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured from third party sources. We make no warranties of any kind in relation to our content, including but not limited to accuracy and updatedness. No part of the content that we provide constitutes financial advice, legal advice or any other form of advice meant for your specific reliance for any purpose. Any use or reliance on our content is solely at your own risk and discretion. You should conduct your own research, review, analyse and verify our content before relying on them. Trading is a highly risky activity that can lead to major losses, please therefore consult your financial advisor before making any decision. No content on our Site is meant to be a solicitation or offer.